Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04284657 · ClinicalTrials.gov registry record · Phase 2
Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
A Phase 2 study, sponsored by University of Southern California.
- Completed
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT04284657 is a Phase 2 study that has completed, run by University of Southern California. The registered enrollment target is 1 participants.
The verdict
NCT04284657, a Phase 2 study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
This is an one-year open-label study to determine treatment efficacy and feasibility of a trial that uses open-label interventions in ADPKD patients.
Interventions
- DRUG Pravastatin
- DRUG sodium citrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-01-30 |
| Est. Completion | 2025-08-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04284657
The ClinicalTrials.gov registry entry for NCT04284657 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pravastatin is the first listed.
NCT04284657 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04284657 about?
NCT04284657 is a clinical study titled "Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease". This is an one-year open-label study to determine treatment efficacy and feasibility of a trial that uses open-label interventions in ADPKD patients.
What is the current status of trial NCT04284657?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2019-01-30. Estimated completion is 2025-08-04.
What interventions are being tested in trial NCT04284657?
The interventions under investigation include: Pravastatin (DRUG), sodium citrate (DRUG).
Who is sponsoring clinical trial NCT04284657?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.